Publications by authors named "A M Saracino"

Background: BICSTaR is a multi-national, observational cohort evaluating the effectiveness, safety, and patient-reported outcomes (PROs) in treatment-naïve (TN) and -experienced (TE) people with HIV-1 receiving bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in routine clinical care. We present the 12-month (M12) outcomes of the Italian BICSTaR cohort.

Methods: Participants initiating B/F/TAF in routine care were prospectively followed.

View Article and Find Full Text PDF

Rationale: Doravirine (DOR) is an attractive new option both for ART-naïve people with HIV (PWH) and those with suppressed HIV-RNA who seek treatment simplification. We used real-world data to examine the pattern of use of DOR-containing regimens in these settings.

Methods: All PWH enrolled in the Icona cohort after January 2020 who initiated a three-drug regimen (3-DR) with DOR or an integrase inhibitor (INSTI)-based regimen as first antiretroviral therapy (ART) or when switching ART, with HIV-RNA ≤50 copies/mL, were included.

View Article and Find Full Text PDF
Article Synopsis
  • Climate change is causing more frequent and intense tropical cyclones in Mozambique, leading to health crises like cholera outbreaks, particularly after Cyclones Idai and Kenneth in 2019.
  • A study in Cabo Delgado Province investigated factors contributing to acute watery diarrhea (AWD) and cholera, surveying 1,615 households to analyze the impact of climate disasters and armed conflict on health.
  • Key risk factors identified included overcrowding, poor access to safe water, and inadequate handwashing facilities, highlighting the need for targeted climate adaptation policies to improve community health.
View Article and Find Full Text PDF
Article Synopsis
  • Long COVID is a significant public health issue affecting many individuals, with this study aiming to identify predictors of its development and specific symptoms over time.
  • The study involved over 1,000 hospitalized COVID-19 patients in Italy, using structured phone questionnaires to assess long COVID incidence and symptoms after a median follow-up of 19 months.
  • Results indicated that 91.7% experienced long COVID, particularly affecting respiratory and neurological systems, with vaccination reducing symptom odds and Delta variant infection greatly increasing the risk for neuropsychiatric symptoms.
View Article and Find Full Text PDF